Patent details

Basic Information

Publication number:

EP2588130

PCT Application Number:

PCT/US/2011/041924

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP117990358

PCT Publication Number:

WO/2011/163648

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CNS DELIVERY OF THERAPEUTIC AGENTS

French Title of Invention:

ADMINISTRATION AU SNC D'AGENTS THÉRAPEUTIQUES

German Title of Invention:

ABGABE THERAPEUTISCHER MITTEL IN DAS ZNS

SPC Number:

Dates

Filing date:

25/06/2011

Grant date:

17/08/2016

EP Publication Date:

17/08/2016

PCT Publication Date:

29/12/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/05/2013

EP B1 Publication Date:

17/08/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

25/06/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

10/02/2023

 

 

Name:

Takeda Pharmaceutical Company Limited

Address:

1-1, Doshomachi 4-chome Chuo-ku, 541-0045, Osaka-shi, Osaka, Japan (JP)

History of Owners

From:

07/10/2016

To:

10/02/2023

Name:

Shire Human Genetic Therapies Inc.

Address:

300 Shire Way, Lexington, MA 02421, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

19/10/2016

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

POWELL Jan.

Address:

United States (US)

2

Name:

SHAHROKH Zahra

Address:

United States (US)

3

Name:

CHARNAS Lawrence.

Address:

United States (US)

4

Name:

CALIAS Pericles

Address:

United States (US)

5

Name:

PAN Jing.

Address:

United States (US)

6

Name:

WRIGHT Teresa Leah.

Address:

United States (US)

7

Name:

PFEIFER Richard.

Address:

United States (US)

8

Name:

MCCAULEY Thomas

Address:

United States (US)

Priority

1

Priority Number:

358857 P

Priority Date:

25/06/2010

Priority Country:

United States (US)

2

Priority Number:

360786 P

Priority Date:

01/07/2010

Priority Country:

United States (US)

3

Priority Number:

387862 P

Priority Date:

29/09/2010

Priority Country:

United States (US)

4

Priority Number:

201161435710

Priority Date:

24/01/2011

Priority Country:

United States (US)

5

Priority Number:

201161442115

Priority Date:

11/02/2011

Priority Country:

United States (US)

6

Priority Number:

201161476210

Priority Date:

15/04/2011

Priority Country:

United States (US)

7

Priority Number:

201161495268

Priority Date:

09/06/2011

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 38/47;

Publication

Bulletin

Bulletin Heading:

CO

Bulletin edition number:

2023/03

Publication date:

01/03/2023

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20230000053A

Date Registered:

10/02/2023

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Takeda Pharmaceutical Company Limited

Address:

1-1, Doshomachi 4-chome Chuo-ku, 541-0045, Osaka-shi, Osaka, Japan (JP)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

30/06/2026

Annual Fee Number:

16

Annual Fee Amount:

230 Euro

Expected Payer:

Last Annual Fee Payment Date:

23/05/2025

Last Annual Fee Paid Number:

15

Last Annual Fee Paid Amount:

213 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages
10/02/2023	Request For Change	46
10/02/2023	Outgoing Correspondence	1